Assenagon Asset Management’s FNB Corp FNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Sell
107,444
-839,971
-89% -$15M ﹤0.01% 844
2026
Q1
$15.8M Buy
+947,415
New +$16.4M 0.02% 379
2025
Q1
Sell
-929,683
Closed -$13.7M 1224
2024
Q4
$13.7M Buy
929,683
+772,134
+490% +$11.8M 0.02% 425
2024
Q3
$2.22M Buy
+157,549
New +$2.25M ﹤0.01% 943
2022
Q4
Sell
-97,891
Closed -$1.14M 1390
2022
Q3
$1.14M Sell
97,891
-1,004,333
-91% -$11.9M ﹤0.01% 900
2022
Q2
$12M Buy
1,102,224
+1,072,515
+3,610% +$12.5M 0.04% 327
2022
Q1
$370K Buy
+29,709
New +$391K ﹤0.01% 1261
2021
Q3
Sell
-34,869
Closed -$430K 1334
2021
Q2
$430K Sell
34,869
-39,938
-53% -$519K ﹤0.01% 1059
2021
Q1
$950K Buy
+74,807
New +$865K ﹤0.01% 940
2020
Q4
Sell
-26,889
Closed -$182K 1103
2020
Q3
$182K Sell
26,889
-118,711
-82% -$871K ﹤0.01% 1079
2020
Q2
$1.09M Buy
+145,600
New +$1.1M 0.01% 768

Other funds holding FNB

Assenagon Asset Management's FNB Position: Q2 2026 in Review

Assenagon Asset Management reduced its FNB Corp (FNB) stake by 89% in Q2 2026, selling an estimated $15M and leaving 107,444 shares worth $2.05M. The position accounts for ﹤0.01% of the portfolio, ranked #844.

Assenagon Asset Management first reported a position in FNB in Q2 2020 and has held it in 11 quarters since. The position peaked at $15.8M in Q1 2026. 81 funds tracked by Wall St. Rank hold FNB as of Q2 2026.

  • Assenagon Asset Management held 107,444 shares of FNB Corp worth $2.05M as of Q2 2026.
  • Assenagon Asset Management sold 839,971 FNB Corp shares in Q2 2026, an estimated $15M.
  • FNB Corp made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #844 holding.
  • Assenagon Asset Management first reported a position in FNB Corp in Q2 2020 and has held it in 11 quarters since.
  • Assenagon Asset Management's FNB Corp position peaked at $15.8M in Q1 2026.
  • 81 funds tracked by Wall St. Rank held FNB Corp as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.